Malavolti M, Fromm H, Ceryak S, Shehan K L
Department of Medicine, George Washington University Medical Center, Washington, D.C. 20037.
Lipids. 1989 Jul;24(7):673-6. doi: 10.1007/BF02535089.
The binding of lithocholic acid to different plasma fractions was studied. When whole plasma was incubated for 8 hr, approximately 25% of the incubated [14C]lithocholic acid was bound to the lipoprotein and lipoprotein-free, albumin-rich fractions. An average of 87.6% of the bound-lithocholic acid was present in the lipoprotein-free, albumin-rich fraction, 7.2% in high density lipoproteins, 2.2% in low density lipoproteins, 1.0% in intermediate density lipoproteins and 2.0% in very low density lipoproteins. Expressed as binding per microgram protein, considerably less [14C]lithocholic acid was bound to the lipoprotein-free, albumin-rich fraction, than to the lipoproteins. The binding of [14C]lithocholic acid after the incubation of the isolated plasma fractions was similar to that found after the incubation of whole plasma. The highest transfer of [14C]lithocholic acid occurred from the lipoprotein-free, albumin-rich fraction to the lipoprotein fractions. The studies indicate, that, although the largest amount of lithocholic acid is bound to the lipoprotein-free, albumin-rich fraction, per microgram protein, the binding of lithocholic acid to lipoproteins is more pronounced and stable than that bound to the lipoprotein-free, albumin-rich fraction. Since lipoproteins, in contrast to albumin, are internalized by most tissues, they may be important carriers into cells of lithocholic acid and other potentially toxic or tumorigenic bile acids.
研究了石胆酸与不同血浆组分的结合情况。当全血浆孵育8小时时,约25%的孵育[14C]石胆酸与脂蛋白以及无脂蛋白、富含白蛋白的组分结合。结合的石胆酸平均有87.6%存在于无脂蛋白、富含白蛋白的组分中,7.2%存在于高密度脂蛋白中,2.2%存在于低密度脂蛋白中,1.0%存在于中间密度脂蛋白中,2.0%存在于极低密度脂蛋白中。以每微克蛋白质的结合量表示,与脂蛋白相比,[14C]石胆酸与无脂蛋白、富含白蛋白的组分的结合量要少得多。分离的血浆组分孵育后[14C]石胆酸的结合情况与全血浆孵育后的情况相似。[14C]石胆酸从无脂蛋白、富含白蛋白的组分向脂蛋白组分的转移量最大。这些研究表明,虽然石胆酸的最大量与无脂蛋白、富含白蛋白的组分结合,但以每微克蛋白质计,石胆酸与脂蛋白的结合比与无脂蛋白、富含白蛋白的组分的结合更显著且更稳定。由于与白蛋白不同,脂蛋白可被大多数组织内化,它们可能是石胆酸和其他潜在有毒或致瘤性胆汁酸进入细胞的重要载体。